Cite
HARVARD Citation
Kawagishi, N. et al. (2017). Comparing the risk of hepatitis B virus reactivation between direct‐acting antiviral therapies and interferon‐based therapies for hepatitis C. Journal of viral hepatitis. 24 (12), pp. 1098-1106. [Online].